Mean (SD) scores and results of planned intention-to-treat analyses comparing health outcomes in control and intervention groups at 6 month primary study end point
| Baseline | 6 months | |||||||
|---|---|---|---|---|---|---|---|---|
| Control(N = 47) | Intervention(N = 45) | Control(N = 42) | Intervention(N = 42) | Unadjusted difference*(95% CI) | p value* | Adjusted difference†(95% CI) | p value† | |
| *Recruitment source only included as a random factor in the ANOVA model. | ||||||||
| †Adjusted for baseline differences in sex, age at leaving full time education, and recent Accident & Emergency attendance or admission. | ||||||||
| Primary outcome | ||||||||
| Asthma symptom control score(range 0–9, lower = better) | 5.11 (3.00) | 6.06 (3.11) | 4.00 (2.91) | 4.21 (3.50) | −0.20 (−1.54 to 1.14) | 0.77 | −0.35 (−1.83 to 1.13) | 0.64 |
| Secondary outcomes | ||||||||
| Asthma quality of life score(range 0–2, lower = better) | 1.14 (0.40) | 1.20 (0.41) | 1.04 (0.40) | 1.02 (0.45) | 0.03 (−0.15 to 0.21) | 0.74 | 0.05 (−0.16 to 0.25) | 0.65 |
| SF-36 physical function score(range 0–100, higher = better) | 55.33 (26.83) | 50.85 (31.46) | 55.36 (29.56) | 52.98 (31.59) | 1.97 (−11.38 to 15.33) | 0.77 | 3.10 (−11.42 to 17.63) | 0.67 |
| SF-36 mental health score(range 0–100, higher = better) | 62.49 (22.14) | 58.81 (23.01) | 66.19 (20.82) | 66.19 (22.30) | −0.40 (−9.98 to 9.18) | 0.93 | 0.42 (−10.22 to 11.07) | 0.94 |